Anika Therapeutics Inc (OQ:ANIK)

Business Focus: Biopharmaceuticals

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ANIK within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 3rd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 28/20 Apr 26/20 Blanchard Cheryl R Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 104,638  
Apr 28/20 Apr 26/20 Blanchard Cheryl R Direct Ownership Restricted Stock Unit A - Grant, award or other under Rule 16b-3(d) 73,726  
Apr 28/20 Apr 26/20 Blanchard Cheryl R Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,794 $33.40
Apr 28/20 Apr 26/20 Blanchard Cheryl R Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,231  
Mar 6/20 Mar 4/20 Colleran David Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 35,000  
Mar 6/20 Mar 4/20 Colleran David Direct Ownership Restricted Stock Unit A - Grant, award or other under Rule 16b-3(d) 7,500  
Feb 27/20 Feb 26/20 Land Raymond J Direct Ownership Common Stock S - Open market or private sale -2,700 $42.68
Feb 27/20 Feb 26/20 Finnerty Thomas Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -881 $42.25
Feb 27/20 Feb 26/20 Finnerty Thomas Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 3,000  
Feb 27/20 Feb 26/20 Cheung Sylvia Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -881 $42.25
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ANIK within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 3rd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Apr 28/20 Apr 26/20 Blanchard Cheryl R Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 104,638  
Apr 28/20 Apr 26/20 Blanchard Cheryl R Direct Ownership Restricted Stock Unit A - Grant, award or other under Rule 16b-3(d) 73,726  
Apr 28/20 Apr 26/20 Blanchard Cheryl R Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,794 $33.40
Apr 28/20 Apr 26/20 Blanchard Cheryl R Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 4,231  
Mar 6/20 Mar 4/20 Colleran David Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 35,000  
Mar 6/20 Mar 4/20 Colleran David Direct Ownership Restricted Stock Unit A - Grant, award or other under Rule 16b-3(d) 7,500  
Feb 27/20 Feb 26/20 Land Raymond J Direct Ownership Common Stock S - Open market or private sale -2,700 $42.68
Feb 27/20 Feb 25/20 Land Raymond J Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 4,107  
Feb 27/20 Feb 25/20 Finnerty Thomas Direct Ownership Restricted Stock Unit A - Grant, award or other under Rule 16b-3(d) 8,500  
Feb 27/20 Feb 26/20 Finnerty Thomas Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -881 $42.25
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ANIK

Competitors

Competitors with Recent Insider Filings
Allakos (OQ:ALLK)
ChemoCentryx (OQ:CCXI)
BioMarin Pharmaceutical (OQ:BMRN)